If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Letizia Giancola is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles
HIV Medicine & Life Sciences
Progressive Multifocal Leukoencephalopathy Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Acquired Immunodeficiency Syndrome Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
JC Virus Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 1341 Citations
  • 18 h-Index
  • 46 Article
  • 1 Letter

Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis

Spallanzani Group for Malaria Study, Jan 1 2019, In : PLoS One. 14, 11, p. e0225135 9 p.

Research output: Contribution to journalArticle

Critical Care
malaria
Malaria
risk factors
Intensive care units

Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment

ATAD Study Group, Bellagamba, R., Giancola, M. L., Tommasi, C., Piselli, P., Tempestilli, M., Angeletti, C., Zaccarelli, M., Ammassari, A., Pinnetti, C., Gallo, A. L., Antinori, A., Narciso, P. & Nicastri, E., Mar 1 2019, In : AIDS (London, England). 33, 3, p. 493-502 10 p.

Research output: Contribution to journalArticle

Tenofovir
efavirenz
Randomized Controlled Trials
Therapeutics
CD4 Lymphocyte Count